http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-286292-A5

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a157f5faa443ba5bb3367371f1e2a6c7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
filingDate 1989-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b533c4923149e5e8a0d9893b8b4be48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55c73cca7df661eed8839476eacf581e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcbaa7c000a5f7d482878be8a436c7db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8076d8f131e52c0c20cac608b4a9f3ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47bb761f772f42af7439d976e54665ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f98f73cc4b9dd62df645fb0d9ae840c
publicationDate 1991-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-286292-A5
titleOfInvention METHOD FOR THE PRODUCTION OF VETERINAL MEDICINE PREPARATIONS SUITABLE FOR THE TREATMENT OF MASTITIS IN COWS
abstract The invention relates to a process for the production of veterinary medicinal preparations suitable for the treatment of mastitis in cows with inoculated liotropic liquid crystal structure. The process is characterized in that it comprises a solution or suspension containing 5-15% by weight of one or more surfactants having at least 8 carbon atoms, 10-40% by weight of water-immiscible solvents and 30-60% by mass of auxiliaries, with an active ingredient mixture containing 5-15 parts by weight in% of a compound of general formula I or an apparent from the claim other compound, for. B. * with a particle size of less than 100mm and an aminoglikoside antibiotic, such as streptomycin, dihydrostreptomycin, neomycin, gentamycin, sisomycin, methylmycin, tolremycin or their salts, in a mixing ratio of * vaccine and optionally mixed with other additives. In formula I, R u. a. amino-substituted benzyl or phenoxy-substituted alkyl, R1-CHR3R4 with R3 phenyl, cyano or -S-CH2CN and R4 denotes H, amino or hydroxyl and R2 denotes methyl, 1-methyl-1H-tetrazol-5-yl-thiomethyl or acetoxymethyl. Formula I {method; manufacture; preparations; combating; Mastitis; cows; Aminoglikosidantibiotikum; additives; Fluessigkristallstruktur; veterinaermedizinisch}
priorityDate 1988-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448361858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415868567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID185639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425330703

Total number of triples: 40.